Systemic BCG-osis following intravesical BCG instillation for bladder carcinoma

Intravesical instillation of Bacillus Calmette-Guérin (BCG) has been shown to be an effective form of immunotherapy for bladder cancer. This case report describes a patient who develops systemic BCG-osis following intravesical BCG instillation and demonstrates the importance of being aware of more severe complications associated with BCG immunotherapy.

Clinical case reports. 2017 Aug 15*** epublish ***

Frank Liaw, Yan Yu Tan, David Hendry

Department of UrologyQueen Elizabeth University HospitalGlasgowG51 4TFUK., Department of GastroenterologyMonklands HospitalAirdrieML6 0JSUK.

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe